First Time Loading...

Rigel Pharmaceuticals Inc
NASDAQ:RIGL

Watchlist Manager
Rigel Pharmaceuticals Inc Logo
Rigel Pharmaceuticals Inc
NASDAQ:RIGL
Watchlist
Price: 1.07 USD -2.73% Market Closed
Updated: Apr 30, 2024

Wall Street
Price Targets

RIGL Price Targets Summary
Rigel Pharmaceuticals Inc

Wall Street analysts forecast RIGL stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for RIGL is 4.66 USD with a low forecast of 1.67 USD and a high forecast of 15.75 USD.

Lowest
Price Target
1.67 USD
56% Upside
Average
Price Target
4.66 USD
335% Upside
Highest
Price Target
15.75 USD
1 372% Upside
Rigel Pharmaceuticals Inc Competitors:
Price Targets
688278
Xiamen Amoytop Biotech Co Ltd
19% Downside
NKTX
Nkarta Inc
184% Upside
MRUS
Merus NV
38% Upside
300294
China Resources Boya Bio pharmaceutical Group Co Ltd
7% Upside
VRTX
Vertex Pharmaceuticals Inc
20% Upside
SPRO
Spero Therapeutics Inc
431% Upside
LYEL
Lyell Immunopharma Inc
172% Upside
KURN
Kuros Biosciences AG
213% Upside

Revenue
Forecast

Revenue Estimate
Rigel Pharmaceuticals Inc

For the last 8 years the compound annual growth rate for Rigel Pharmaceuticals Inc's revenue is 19%. The projected CAGR for the next 3 years is 26%.

19%
Past Growth
26%
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Rigel Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-6%
Average Miss

Net Income
Forecast

Net Income Estimate
Rigel Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-22%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is RIGL's stock price target?
Price Target
4.66 USD

According to Wall Street analysts, the average 1-year price target for RIGL is 4.66 USD with a low forecast of 1.67 USD and a high forecast of 15.75 USD.

What is Rigel Pharmaceuticals Inc's Revenue forecast?
Projected CAGR
26%

For the last 8 years the compound annual growth rate for Rigel Pharmaceuticals Inc's revenue is 19%. The projected CAGR for the next 3 years is 26%.